| ID | 10120 |
| Vaccine Name | Rabivax-S |
| Disease Name | Rabies |
| Disease Classification | Neurologic |
| Virus Name | Rabies virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Ross University School of Veterinary Medicine |
| Year of Manufacturing | 2019 |
| Manufacturing Country | India |
| Age | All age group |
| Dosage | 3 doses on day 0, 7 and 21 |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | Human diploid cell vaccine |
| Approving Organisation | DCGI |
| Collaborating Organisation | Serum Institute of India |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT03741270 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT03741270 |
| Additional Links | http://test.pharmabiz.com/news/serum-institute-launches-rabies-vaccine-rabivax-24382
|